The pretreatment neutrophil-to-lymphocyte ratio is a novel biomarker for predicting clinical responses to pembrolizumab in platinum-resistant metastatic urothelial carcinoma patients
2020 ◽
Vol 38
(6)
◽
pp. 602.e1-602.e10
◽
2015 ◽
Vol 22
(7)
◽
pp. 638-643
◽
2017 ◽
Vol 15
(3)
◽
pp. e469-e476
◽
2019 ◽
Vol 18
(1)
◽
pp. e2110-e2111
◽
2014 ◽
Vol 12
(2)
◽
pp. e69-e70
◽